LANDMARK trial: Update in study protocol
- PMID: 38369219
- DOI: 10.1016/j.ahj.2024.02.008
LANDMARK trial: Update in study protocol
Conflict of interest statement
Conflicts of Interest Akihiro Tobe received a grant from Fukuda foundation for medical therapy. Andreas Baumbach received lecture fees from Astra Zeneca and Microport. Andereas Baumbach is a participant of advisory board of Pi-Cardia and Faraday. Patrick W Serruys received consulting fees from Philips/Volcano, SMT, Novartis and Xeltis.
Comment on
-
Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial.Am Heart J. 2021 Feb;232:23-38. doi: 10.1016/j.ahj.2020.11.001. Epub 2020 Nov 6. Am Heart J. 2021. PMID: 33160946
Publication types
LinkOut - more resources
Full Text Sources
Medical
